You have 9 free searches left this month | to do more

daratumumab

Daratumumab is a drug used to treat Multiple Myeloma, Plasma Cell Myeloma, Myeloma, and other conditions. Daratumumab is being actively studied in 118 studies and prior, has been studied in 20.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCColorado Blood Cancer InstituteFernando Fervenza
Mayo ClinicMayo ClinicAjai Chari
CelgeneHosp. Clinico Univ. de SalamancaAjay Nooka
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
2022-04-04
Apr 4, 2022
S
Withdrawn
  • Multiple Myeloma
  • Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2022-03-25
Mar 25, 2022
J
Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-02-24
Feb 24, 2022
C
Completed
  • Multiple Myeloma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-03-09
Mar 9, 2022
T
Recruiting
  • Multiple Myeloma
  • Lenalidomide Pill
  • +2 more
  • Indianapolis, Indiana
    VA Roudebush Medical Center
2022-01-27
Jan 27, 2022
A
Not yet recruiting
  • Plasma Cell Leukemia
  • Daratumumab
  • (no location specified)
2021-09-22
Sep 22, 2021
M
Active, not recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2022-03-25
Mar 25, 2022
W
Not yet recruiting
  • Glioblastoma
  • Daratumumab
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021
W
Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
2021-12-21
Dec 21, 2021
M
Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-05-19
May 19, 2021
F
Completed
  • Membranoproliferative Glomerulonephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic
2021-06-28
Jun 28, 2021
M
Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2022-03-22
Mar 22, 2022
W
Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
P
Recruiting
  • Amyloidosis; Systemic
  • Daratumumab
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
B
Completed
  • AL Amyloidosis
  • daratumumab
  • Boston, Massachusetts
    Boston Medical Center
2021-04-15
Apr 15, 2021
T
Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab
  • (no location specified)
2021-10-10
Oct 10, 2021
H
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center
2022-03-04
Mar 4, 2022
C
Completed
  • Multiple Myeloma in Relapse
  • Daratumumab
  • Kingston, Ontario, Canada
  • +5 more
2022-02-14
Feb 14, 2022
M
Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
H
Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Washington, District of Columbia
  • +1 more
2022-02-03
Feb 3, 2022
W
Recruiting
  • Amyloid
  • +2 more
  • Daratumumab
  • +2 more
  • Palo Alto, California
  • +3 more
2021-06-23
Jun 23, 2021
C
Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
2021-12-27
Dec 27, 2021
U
Completed
  • Amyloidosis
  • Daratumumab
  • Angers, France
  • +9 more
2021-07-08
Jul 8, 2021
D
Active, not recruiting
  • Waldenström Macroglobulinemia
  • Daratumumab
  • Boston, Massachusetts
  • +4 more
2021-04-21
Apr 21, 2021